Human Paraoxonase

Updated: 2026-07-15

Overview

Human paraoxonase (PON1) is a calcium-dependent enzyme primarily synthesized in the liver and secreted into the bloodstream. It belongs to a family of enzymes known for their ability to hydrolyze organophosphate compounds, lactones, and lipid peroxides. PON1 is closely associated with high-density lipoproteins (HDLs) and plays a dual role in detoxification and antioxidant protection. Research has linked PON1 activity to cardiovascular health, as it helps prevent the oxidation of low-density lipoproteins (LDLs). Genetic polymorphisms in the PON1 gene can significantly influence enzyme activity, making it a subject of interest in personalized medicine and toxicology studies.

Physical and Chemical Properties

PON1 is a glycoprotein with a molecular weight ranging between 43-45 kDa, depending on post-translational modifications. The enzyme exhibits optimal activity at physiological pH (7.4-8.0) and requires calcium ions as cofactors. Its structure includes a six-bladed beta-propeller fold, which stabilizes its active site for substrate binding. PON1 demonstrates broad substrate specificity, efficiently hydrolyzing paraoxon (a toxic organophosphate), aromatic esters, and lactones. Its stability varies with storage conditions; lyophilized forms retain activity longer than liquid solutions. Temperature sensitivity requires storage at -20°C or below, with reconstitution in calcium-containing buffers for experimental use.

Main Applications

In medical research, PON1 is studied for its role in mitigating atherosclerosis and neurodegenerative diseases due to its antioxidant properties. Clinically, low PON1 activity is considered a risk marker for cardiovascular events. The enzyme also serves as a biomarker in occupational health to assess exposure to organophosphate pesticides. Environmental applications include bioremediation, where PON1 variants are engineered for enhanced organophosphate degradation. Pharmaceutical development explores PON1 mimetics as potential therapeutics for oxidative stress-related disorders. Industrial uses are limited but include enzyme-assisted detoxification processes in pesticide manufacturing.

Safety and Storage

While PON1 itself is non-toxic, it interacts with hazardous substrates like organophosphates. Standard laboratory biosafety level (BSL-1 or BSL-2) practices are recommended when handling these combinations. Use personal protective equipment (PPE) to avoid accidental exposure during experiments. For storage, lyophilized PON1 should be kept at -20°C in airtight containers with desiccants to prevent moisture absorption. Liquid formulations require aliquoting to minimize freeze-thaw cycles, which can degrade enzymatic activity. Always verify activity via kinetic assays after prolonged storage.

B2B Procurement Guide

When procuring PON1 for research or industrial use, prioritize suppliers that provide certificates of analysis (CoA) detailing purity (>95%), specific activity (units/mg), and endotoxin levels. Recombinant human PON1 is preferable for consistency, though native forms from serum are also available. Bulk purchases (100+ mg) may qualify for discounted rates, but confirm batch-to-batch consistency. For specialized applications (e.g., clinical assays), request custom formulations with stabilized buffers. Lead times can vary; GMP-grade PON1 often requires 6-8 weeks for production and quality control.